{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383388843682799366.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Brian A Ference"}],"foaf:familyName":[{"@value":"Ference"}],"foaf:givenName":[{"@value":"Brian A"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363388843682799488","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1093/eurheartj/ehz455"},{"@type":"URI","@value":"https://academic.oup.com/eurheartj/article-pdf/41/1/111/66477601/eurheartj_41_1_111.pdf"}],"notation":[{"@value":"2019 ESC/EAS Guidelines for the management of dyslipidaemias:\n                    <i>lipid modification to reduce cardiovascular risk</i>"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/eurheartj/ehz455_N1p2FpSg2ZWyh6nbm1MZC3hZUJH"}]}